Mirova Portfolio holdings
Mirova is a Paris-based asset manager devoted to sustainable investing and an affiliate of Natixis Investment Managers. Philippe Zaouati founded it in 2012 as a department of Natixis Asset Management (later renamed Ostrum Asset Management), and in 2014 it became a direct affiliate of Natixis Investment Managers. Mirova aims to build every portfolio to fit a climate path below 2°C, and its Althelia funds invest in the sustainable management of land and marine resources. It bought SunFunder, a Nairobi-based specialist in clean energy and climate investment in emerging markets, in 2022, and in 2020 became a mission-driven company under French law.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$82.9M |
| 2 |
Mastercard
MA
|
+$80.3M |
| 3 |
Microsoft
MSFT
|
+$80.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$74M |
| 5 |
Danaher
DHR
|
+$73.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$1.63M |
| 2 |
Johnson & Johnson
JNJ
|
+$302K |
| 3 |
Abbott
ABT
|
+$251K |
| 4 |
Voya Financial
VOYA
|
+$207K |
| 5 |
Rockwell Automation
ROK
|
+$172K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.22% |
| 2 | Technology | 22.57% |
| 3 | Financials | 15.16% |
| 4 | Materials | 10.65% |
| 5 | Utilities | 8.38% |
Similar funds
Mirova's Q2 2019 Portfolio in Review
As of Q2 2019, Mirova held 135 positions worth $1.13B, up 513% from $184M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Mirova deployed $898M of net new capital in Q2 2019, opening 36 new positions and adding to 32 existing holdings. Its largest new stake was Church & Dwight Co: 39,716 shares worth $2.9M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was First Solar, an estimated $1.63M trimmed.
- Mirova's largest Q2 2019 buy was Church & Dwight Co: 39,716 shares worth $2.9M.
- Mirova added most to Thermo Fisher Scientific in Q2 2019, an estimated $82.9M increase.
- Mirova's biggest Q2 2019 reduction was First Solar, cutting an estimated $1.63M.
- Mirova fully exited Johnson & Johnson in Q2 2019, selling an estimated $302K.
- Mirova's ten largest holdings make up 69% of its $1.13B portfolio in Q2 2019.
- Mirova opened 36 new positions and closed 6 in Q2 2019.
- Mirova's portfolio value rose 513% quarter-over-quarter to $1.13B.
Based on Mirova's 13F filing for Q2 2019, filed 13 Aug 2019.